Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
Jennifer Kouznetsova(National Institutes of Health), Adolfo García‐Sastre(Office of Infectious Diseases), John C. McKew(National Institutes of Health), Wei Zheng(Liaoning Cancer Hospital & Institute), Aaron D. Schimmer(University of Toronto), Philip E.J. Sanderson, Gregory J. Tawa(National Institutes of Health), Wei Sun(National Institutes of Health), Catherine Z. Chen(National Institutes of Health), Paul Shinn(National Institutes of Health), Carles Martínez‐Romero(Icahn School of Medicine at Mount Sinai)
Cited by 242
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Human host factors required for influenza virus replication
|Nature|2009|825